Industry Payments by Physician Specialty: Reading the 2025 CMS Data
Comparing industry payments across medical specialties requires more than sorting dollar totals. The comparison needs one payment year, a defined physician population, and a consistent way to assign specialties. Total dollars, average dollars per recipient, and payment concentration answer different questions; none alone measures clinical quality or prescribing influence.
This guide covers CMS Open Payments Program Year 2025 general payments and explains how to evaluate a physician-specialty comparison. It does not present a calculated Top 10. Industry is used broadly here: the scope is not restricted to pharmaceutical companies.
Table of contents
- Start with the right payment population
- Make specialty groups comparable
- Choose the measure that answers the question
- Check the denominator and record counts
- Read a specialty comparison critically
- Frequently asked questions
- Sources
Start with the right payment population
CMS reports $3.92 billion in general payments for Program Year 2025. That is a program-wide total, not a total restricted to U.S. physicians. It cannot be combined with an unrelated physician count to calculate a specialty average.
The payment year is 2025; publication followed in 2026. A valid comparison keeps that measurement period separate from a webpage's publication or modification date.
For a U.S. physician analysis, select general-payment records for physician recipients under the CMS covered-recipient definition and apply a stated U.S. address rule. Exclude teaching hospitals and nonphysician practitioners. Research payments and ownership or investment interests belong to separate categories.
Also define what “physician” means. An MD/DO-only study differs from one using CMS's broader physician categories. A comparison should name its choice rather than silently change the population between specialties.
The reporting-entity universe spans covered products beyond drugs, including devices and medical supplies. A broad industry comparison should not be relabeled as pharmaceutical-company payments.
Make specialty groups comparable
Open Payments can record several specialties for a recipient. The January 2026 documentation lists up to six specialty fields, so an analysis should not assume every recipient has exactly one specialty or that the first field is officially designated “primary.”
Three choices affect the result:
- Classification level. Compare broad specialties with broad specialties, or subspecialties with subspecialties. A parent group and its component groups are not parallel categories.
- Assignment rule. Explain how a recipient with multiple specialties is assigned. If the goal is a mutually exclusive spending allocation, each payment must contribute to one group only.
- Unclassified records. Retain a visible category for missing, unknown, or unresolved specialties rather than silently excluding their dollars.
For example, counting the same payment once under a broad specialty and again under a related subspecialty inflates an additive specialty total. A study can intentionally describe overlapping memberships, but it must label the overlap and cannot present those groups as slices of one non-overlapping whole.
Use the specialty information associated with the selected release consistently. Replacing some records with newer registry information changes the method and requires explanation.
Choose the measure that answers the question
| Measure | Useful for | What it leaves unanswered |
|---|---|---|
| Total general-payment dollars | Comparing disclosed dollar volume | How much a typical physician received |
| Distinct physician recipients | Comparing the number of physicians represented | The size of the full specialty workforce |
| Dollars per represented physician | Comparing an average among recipients | Whether a few large payments drive the average |
| Median recipient-level dollars | Describing the middle recipient | The total scale or full distribution of payments |
Hypothetical example: Specialty A has $2 million across 1,000 physician recipients, while Specialty B has $1.5 million across 300. A leads by total dollars; B has the higher average: $5,000 versus $2,000. These invented values illustrate the difference between volume and an average. They do not identify real leading specialties.
Payment composition matters as well. A specialty total dominated by royalty payments represents a different mix of financial relationships from one dominated by food and beverage. Compare the relevant CMS payment categories before treating similar dollar totals as equivalent patterns.
Check the denominator and record counts
A specialty's share should use eligible dollars from the same population, year, and release as its numerator. If the analysis covers U.S. physician general payments, the denominator must cover that same group. Keep unclassified specialty dollars in the disclosed accounting so readers can see how much spending lies outside named groups.
Payment records, reported payments, and unique recipients are also different units. One record can include several payments; a physician can appear in many records. Count unique payment-record identifiers before summing dollars, and use a validated recipient identifier for person counts.
Do not divide a program-wide dollar total by an all-category physician count and call the result an average general payment to a physician. The two figures need matching scope.
Read a specialty comparison critically
Before using a published table, check that it states:
- The payment year and source release.
- The included physician types and geographic scope.
- Whether the payer universe is broad industry or a documented pharmaceutical subset.
- The specialty level and handling of recipients with multiple specialties.
- The units, denominator, missing-data treatment, and tie rule.
Use the CMS exploration tools to inspect the definitions behind a comparison. An older specialty summary can provide historical context, but its update date does not make its figures a 2025 ranking.
The useful next question is often about composition or concentration: are differences associated with more recipients, larger transfers, or a different mix of payment categories? The disclosure data alone cannot establish why those differences occurred or whether a payment affected care.
Frequently asked questions
Which specialty received the most industry payments in 2025?
This guide does not report a calculated leader. A defensible answer requires a complete comparison using the stated physician population and specialty-assignment method; CMS's overall general-payment total does not supply it.
Is a specialty's average payment representative of its typical physician?
Not necessarily. An average among payment recipients excludes physicians without eligible records and may be affected by unusually large transfers. A median and distribution provide different information.
Does a high total indicate improper influence?
No. Payment totals describe disclosed financial relationships. They do not, by themselves, measure clinical quality, professional integrity, or a causal effect on prescribing.